世界の薬物送達注入装置市場:医療機器パイプライン分析2016

◆英語タイトル:Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 2016
◆商品コード:GDME0209EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年7月4日
◆ページ数:148
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD8,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD12,000 ⇒換算¥1,332,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、薬物送達注入装置のグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。
・薬物送達注入装置の概要
・薬物送達注入装置の開発動向:開発段階別分析
・薬物送達注入装置の開発動向:セグメント別分析
・薬物送達注入装置の開発動向:領域別分析
・薬物送達注入装置の開発動向:規制Path別分析
・薬物送達注入装置の開発動向:承認日(推定)別分析
・企業別薬物送達注入装置の開発動向(パイプライン製品、進行中の治験)
・薬物送達注入装置の最近動向
【レポートの概要】

Drug Delivery Infusion Systems – Medical Devices Pipeline Assessment, 2016

Summary

GlobalData’s Medical Devices sector report, “Drug Delivery Infusion Systems – Medical Devices Pipeline Assessment, 2016″ provides an overview of Drug Delivery Infusion Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Drug Delivery Infusion Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Drug Delivery Infusion Systems under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Drug Delivery Infusion Systems and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Drug Delivery Infusion Systems under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 11
2 Introduction 12
2.1 Drug Delivery Infusion Systems Overview 12
3 Products under Development 14
3.1 Drug Delivery Infusion Systems – Pipeline Products by Stage of Development 14
3.2 Drug Delivery Infusion Systems – Pipeline Products by Segment 15
3.3 Drug Delivery Infusion Systems – Pipeline Products by Territory 16
3.4 Drug Delivery Infusion Systems – Pipeline Products by Regulatory Path 17
3.5 Drug Delivery Infusion Systems – Pipeline Products by Estimated Approval Date 18
3.6 Drug Delivery Infusion Systems – Ongoing Clinical Trials 19
4 Drug Delivery Infusion Systems – Pipeline Products under Development by Companies 20
4.1 Drug Delivery Infusion Systems – Pipeline Products by Stage of Development 20
4.2 Drug Delivery Infusion Systems – Pipeline Products by Stage of Development 22
5 Drug Delivery Infusion Systems Companies and Product Overview 24
5.1 410 Medical Innovation, LLC Company Overview 24
5.1.1 410 Medical Innovation, LLC Pipeline Products & Ongoing Clinical Trials Overview 24
5.2 Acuros GmbH Company Overview 25
5.2.1 Acuros GmbH Pipeline Products & Ongoing Clinical Trials Overview 25
5.3 AktiVax Inc. Company Overview 26
5.3.1 AktiVax Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
5.4 Alnylam Pharmaceuticals, Inc. Company Overview 27
5.4.1 Alnylam Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.5 Anesthesia Safety Products, LLC Company Overview 29
5.5.1 Anesthesia Safety Products, LLC Pipeline Products & Ongoing Clinical Trials Overview 29
5.6 AngioDynamics, Inc. Company Overview 30
5.6.1 AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.7 Automedics Medical Systems Company Overview 34
5.7.1 Automedics Medical Systems Pipeline Products & Ongoing Clinical Trials Overview 34
5.8 Baxter International Inc. Company Overview 35
5.8.1 Baxter International Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.9 BioCardia, Inc. Company Overview 36
5.9.1 BioCardia, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.10 Debiotech S.A. Company Overview 38
5.10.1 Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview 38
5.11 Delpor, Inc. Company Overview 40
5.11.1 Delpor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.12 Edwards Lifesciences Corporation Company Overview 42
5.12.1 Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 42
5.13 Eksigent Technologies, LLC Company Overview 43
5.13.1 Eksigent Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 43
5.14 Eli Lilly and Company Company Overview 45
5.14.1 Eli Lilly and Company Pipeline Products & Ongoing Clinical Trials Overview 45
5.15 Flowonix Medical, Inc. Company Overview 47
5.15.1 Flowonix Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
5.16 FluidSynchrony, LLC Company Overview 48
5.16.1 FluidSynchrony, LLC Pipeline Products & Ongoing Clinical Trials Overview 48
5.17 Fluonic, Inc. Company Overview 49
5.17.1 Fluonic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.18 Fresenius Kidney Care Company Overview 50
5.18.1 Fresenius Kidney Care Pipeline Products & Ongoing Clinical Trials Overview 50
5.19 Imagnus Biomedical Inc. Company Overview 51
5.19.1 Imagnus Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.20 Innovfusion Pte. Ltd. Company Overview 52
5.20.1 Innovfusion Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 52
5.21 Intarcia Therapeutics, Inc. Company Overview 55
5.21.1 Intarcia Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.22 IRadimed Corporation Company Overview 59
5.22.1 IRadimed Corporation Pipeline Products & Ongoing Clinical Trials Overview 59
5.23 Ivenix, Inc. Company Overview 61
5.23.1 Ivenix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
5.24 LifeMedix, LLC Company Overview 63
5.24.1 LifeMedix, LLC Pipeline Products & Ongoing Clinical Trials Overview 63
5.25 Lynntech, Inc. Company Overview 64
5.25.1 Lynntech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
5.26 Medallion Therapeutics, Inc. Company Overview 65
5.26.1 Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
5.27 Medical Device Creations Ltd. Company Overview 66
5.27.1 Medical Device Creations Ltd. Pipeline Products & Ongoing Clinical Trials Overview 66
5.28 MedPrime Technologies Pvt. Ltd. Company Overview 67
5.28.1 MedPrime Technologies Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67
5.29 Mercator MedSystems, Inc. Company Overview 68
5.29.1 Mercator MedSystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68
5.30 Nano Precision Medical Company Overview 72
5.30.1 Nano Precision Medical Pipeline Products & Ongoing Clinical Trials Overview 72
5.31 NexGen Medical Systems, Inc. Company Overview 73
5.31.1 NexGen Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73
5.32 Nipro Corporation Company Overview 74
5.32.1 Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview 74
5.33 Owen Mumford Limited Company Overview 76
5.33.1 Owen Mumford Limited Pipeline Products & Ongoing Clinical Trials Overview 76
5.34 Pavmed Inc Company Overview 77
5.34.1 Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview 77
5.35 PRO-IV Medical Ltd. Company Overview 78
5.35.1 PRO-IV Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 78
5.36 Ratio, Inc. Company Overview 81
5.36.1 Ratio, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
5.37 Rice University Company Overview 82
5.37.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 82
5.38 SteadyMed Therapeutics, Inc. Company Overview 83
5.38.1 SteadyMed Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83
5.39 StnDrd Infusion Corporation Company Overview 85
5.39.1 StnDrd Infusion Corporation Pipeline Products & Ongoing Clinical Trials Overview 85
5.40 Tel Aviv University Company Overview 87
5.40.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 87
5.41 Terumo Corporation Company Overview 88
5.41.1 Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview 88
5.42 ToucheMedical Ltd. Company Overview 90
5.42.1 ToucheMedical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 90
5.43 Unilife Corporation Company Overview 91
5.43.1 Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview 91
5.44 University of Minnesota Company Overview 93
5.44.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 93
5.45 University of Southern California Company Overview 95
5.45.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 95
6 Drug Delivery Infusion Systems – Recent Developments 96
6.1 Jun 16, 2016: Data Show Sigma Spectrum Infusion System Users Achieved 97 Percent Drug Library Compliance Rate within the First Month of Implementation 96
6.2 Jun 14, 2016: IRADIMED Announces Election of Roger Susi as Chairman of the Board 96
6.3 Jun 13, 2016: Aarti Shah named chief information officer 97
6.4 Jun 12, 2016: Intarcia Presents FREEDOM-2 Trial Results in Type 2 Diabetes Demonstrating Clinically Meaningful Superiority and Sustained Glucose Control and Weight Reduction for ITCA 650 vs. Januvia: Oral Presentation at ADA 76th Scientific Sessions 97
6.5 Jun 09, 2016: IRADIMED Provides Regulatory Update 99
6.6 Jun 07, 2016: Intarcia Announces Branding of the Medici Drug Delivery System- A Platform of Technologies Key to Advancing its Pipeline of Once-Yearly Peptide and Antibody Fragment-Based Therapeutics in Poorly Controlled Chronic Diseases 100
6.7 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 100
6.8 Jun 03, 2016: Autostart Burette Listed Through Qld Health Tender 101
6.9 Jun 01, 2016: Phillips-Medisize Acquires Medicom Innovation Partner 101
6.10 Jun 01, 2016: Flowonix Medical Raises USD10.5 Million in Venture Financing 102
6.11 Jun 01, 2016: Flowonix Medical Secures USD5 Million in Venture Debt Financing 102
6.12 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 102
6.13 May 24, 2016: Pyng Medical Reports Second Quarter Fiscal 2016 Results 104
6.14 May 24, 2016: Lilly Details Robust R&D Pipeline to Investment Community 105
6.15 May 23, 2016: Real World Data In Europe Show Majority Of Diabetic Macular Edema Patients Gain Or Maintain Vision With Iluvien At 12 Months 106
6.16 May 23, 2016: Unilife Announces Receipt of Deficiency Letter from NASDAQ 107
6.17 May 18, 2016: Study Finds 90 Percent of Pump Programming Events for High-Alert Infusion Medications are Dose Adjustments 107
6.18 May 18, 2016: Flowonix Medical Appoints Larry Heaton as CEO 108
6.19 May 18, 2016: Repro Med Systems Posts Fourth Quarter and Fiscal Year 2016 Results and Announces New Member of the Board of Directors 109
6.20 May 16, 2016: B. Braun to Showcase Its Innovative Synchronized Intelligence Infusion Platform at AACN 110
6.21 May 13, 2016: ConvaTec Healthcare May Raise USD1 Billion in IPO 110
6.22 May 13, 2016: PAVmed Announces First Quarter 2016 Financial Results 111
6.23 May 11, 2016: Teleflex Raises USD400 Million in Public Offering of 4.875% Notes Due 2026 111
6.24 May 11, 2016: Steadymed Provides Corporate Update And Reports First Quarter 2016 Financial Results 111
6.25 May 10, 2016: B. Braun Medical Calls for ECRI Institute to Establish a Scientific, Protocol-Driven Methodology for Evaluating Infusion Pumps 112
6.26 May 09, 2016: Baxter Highlights Business Strategies and Innovation at 2016 Investor Conference 113
6.27 May 06, 2016: Alimera Sciences’ ILUVIEN Data Presented At 2016 ARVO 114
6.28 May 06, 2016: Intarcia Announces Successful Cardiovascular Safety Results in Phase 3 FREEDOM-CVO Trial for ITCA 650, an Investigational Therapy for Type 2 Diabetes 115
6.29 May 03, 2016: Strong start into the year – Double-digit earnings growth in constant currency – Fresenius confirms Group guidance for 2016 116
6.30 Apr 29, 2016: IRADIMED Announces First Quarter 2016 Financial Results 118
6.31 Apr 15, 2016: InfuSystem to Acquire Infusion Pump Assets from InfusAID 119
6.32 Apr 08, 2016: Fresenius Vamed lays foundation stone for new university hospital building 120
6.33 Apr 01, 2016: IRADIMED Provides Regulatory Update 120
6.34 Mar 29, 2016: Hicks Thomas Represents EMED Technologies Seeking Injunction against RMS Medical Products for Infusion Devices FDA Warns Are Adulterated and Misbranded 120
6.35 Mar 15, 2016: Zyno Medical to Feature Z-800F Set Based Anti-Free-Flow IV Pump at NHIA 121
6.36 Mar 09, 2016: Repro Med Systems Responds to FDA Warning Letter 121
6.37 Feb 26, 2016: Zyno Medical to Feature ZynoFlo Integrated Infusion System at ACCC 121
6.38 Feb 26, 2016: Zyno Medical to Feature Z-800WF IV Infusion Pump at ACCC 122
6.39 Feb 24, 2016: Alaris System Named 2015 Best In KLAS for Smart Pumps 122
6.40 Feb 24, 2016: Outstanding 2015 financial results – 25% dividend increase proposed – Positive outlook for 2016 – New mid-term growth targets 123
6.41 Feb 24, 2016: Aetna and Roxborough Memorial Hospital Agree to Three-Year Contract 127
6.42 Feb 09, 2016: Dr. Seema Kumbhat Named Fresenius Kabi USA Medical Director 128
6.43 Feb 05, 2016: IRADIMED Announces Fourth Quarter 2015 Financial Results 128
6.44 Jan 21, 2016: Mercator MedSystems Announces First Patient Enrolled in Below the Knee Clinical Trial 129
6.45 Jan 20, 2016: LifeFlow Rapid Infuser Receives Innovation Award at Pediatrics 2040 Meeting 130
6.46 Jan 13, 2016: Pfizer May Sell Infusion Pump Business of Hospira 130
6.47 Jan 11, 2016: IRADIMED Announces 2016 Annual and First Quarter Financial Guidance 131
6.48 Jan 06, 2016: Ivenix Appoints MedTech Industry Veteran Stuart A. Randle as Chief Executive Officer 131
6.49 Dec 10, 2015: IRADIMED Updates Status of 510(k) Submission 132
6.50 Dec 02, 2015: Surefire Medical Raises USD15 Million in Series C Financing 132
6.51 Nov 05, 2015: Surefire Medical Raises Additional USD4 Million in Venture Financing 132
6.52 Nov 03, 2015: IRadimed Plans to Raise up to USD40 Million in Public Offering of Shares 133
6.53 Nov 02, 2015: Flowonix Medical and Connecticut Pain Care Announce the First Implant of the Prometra II Pump in Danbury, CT 133
6.54 Oct 30, 2015: IRADIMED Announces Third Quarter 2015 Financial Results 133
6.55 Oct 30, 2015: IRADIMED Announces Dismissal of Appeal 134
6.56 Oct 28, 2015: SteadyMed Announces Positive Clinical Study Results in Support of SMT-201 for the Treatment of Post Surgical Pain in the Home Setting 134
6.57 Oct 23, 2015: Edwards Lifesciences Enters into Agreement with CareFusion 135
6.58 Oct 08, 2015: Smiths Medical Awarded Contract by Novation 135
6.59 Oct 08, 2015: Bespak Launches New Brand Identity To The Market 136
6.60 Oct 05, 2015: Medicom receives the growth award – Borsen Gazelle 2015 136
6.61 Sep 25, 2015: Surefire Medical Introduces New Precision Infusion System 136
6.62 Sep 22, 2015: B. Braun Receives FDA Clearance for Infusomat Space Pump 137
6.63 Sep 03, 2015: pSivida CEO Invited to Speak at Surfaces in BioMaterials Foundation’s BioInterface 2015 Annual Symposium 138
6.64 Sep 01, 2015: Surefire Medical Receives FDA Clearance for Precision Direct-to-Tumor Embolization Device 138
6.65 Aug 27, 2015: Hospira Announces First Installation of Plum 360 Infusion System With Hospira MedNet 138
6.66 Aug 11, 2015: Command Medical Products Announces Promotion to Vice President 139
6.67 Jul 31, 2015: Symbiq Infusion System by Hospira: FDA Safety Communication – Cybersecurity Vulnerabilities 140
6.68 Jul 30, 2015: IRADIMED Announces Second Quarter 2015 Financial Results 140
6.69 Jul 29, 2015: Hospira Reports Second-Quarter 2015 Results 141
6.70 Jul 29, 2015: Fresenius Medical Care Reports Second Quarter 2015 Results And Confirms Guidance For Full Year 2015 142
6.71 Jul 16, 2015: Novo Nordisk Receives FDA Approval for FlexPro PenMate for People with Growth Hormone-Related Disorders 143
6.72 Jul 08, 2015: MicroPort Lifesciences Attends Diabetes and Gonadal Disorders Meeting to Promote La Fenice 144
7 Appendix 145
7.1 Methodology 145
7.2 About GlobalData 147
7.3 Contact Us 148
7.4 Disclaimer 148

1.1 List of Tables
Table 1: Drug Delivery Infusion Systems - Pipeline Products by Stage of Development 14
Table 2: Drug Delivery Infusion Systems - Pipeline Products by Segment 15
Table 3: Drug Delivery Infusion Systems - Pipeline Products by Territory 16
Table 4: Drug Delivery Infusion Systems - Pipeline Products by Regulatory Path 17
Table 5: Drug Delivery Infusion Systems - Pipeline Products by Estimated Approval Date 18
Table 6: Drug Delivery Infusion Systems - Ongoing Clinical Trials 19
Table 7: Drug Delivery Infusion Systems Companies - Pipeline Products by Stage of Development 20
Table 8: Drug Delivery Infusion Systems - Pipeline Products by Stage of Development 22
Table 9: 410 Medical Innovation, LLC Pipeline Products & Ongoing Clinical Trials Overview 24
Table 10: LifeFlow Rapid Infusion System - Product Status 24
Table 11: LifeFlow Rapid Infusion System - Product Description 24
Table 12: Acuros GmbH Pipeline Products & Ongoing Clinical Trials Overview 25
Table 13: Disposable Micropump - Product Status 25
Table 14: Disposable Micropump - Product Description 25
Table 15: AktiVax Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
Table 16: Immunoject - Product Status 26
Table 17: Immunoject - Product Description 26
Table 18: Alnylam Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
Table 19: ALN-HTT Infusion System - Product Status 27
Table 20: ALN-HTT Infusion System - Product Description 28
Table 21: Anesthesia Safety Products, LLC Pipeline Products & Ongoing Clinical Trials Overview 29
Table 22: FloStat Infusion Pump System - Product Status 29
Table 23: FloStat Infusion Pump System - Product Description 29
Table 24: AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
Table 25: BioFlo Portline Line Extension - Product Status 30
Table 26: BioFlo Portline Line Extension - Product Description 31
Table 27: Next Generation BioFlo Port - Product Status 31
Table 28: Next Generation BioFlo Port - Product Description 31
Table 29: Power Injectable Port - Product Status 32
Table 30: Power Injectable Port - Product Description 32
Table 31: Smart Port - Dual - Product Status 32
Table 32: Smart Port - Dual - Product Description 33
Table 33: Automedics Medical Systems Pipeline Products & Ongoing Clinical Trials Overview 34
Table 34: AutoHep System - Product Status 34
Table 35: AutoHep System - Product Description 34
Table 36: Baxter International Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
Table 37: Infusion Pump - Product Status 35
Table 38: Infusion Pump - Product Description 35
Table 39: BioCardia, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
Table 40: Helix Transendocardial Delivery System - Product Status 36
Table 41: Helix Transendocardial Delivery System - Product Description 37
Table 42: Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview 38
Table 43: MIP Device - Product Status 38
Table 44: MIP Device - Product Description 39
Table 45: Delpor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
Table 46: Delpor Microfabricated Nanopore Device - Product Status 40
Table 47: Delpor Microfabricated Nanopore Device - Product Description 41
Table 48: Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 42
Table 49: Integrated Semi-Closed Loop System - Product Status 42
Table 50: Integrated Semi-Closed Loop System - Product Description 42
Table 51: Eksigent Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 43
Table 52: External Drug Delivery System - Product Status 43
Table 53: External Drug Delivery System - Product Description 43
Table 54: Implantable Drug Delivery System - Product Status 44
Table 55: Implantable Drug Delivery System - Product Description 44
Table 56: Eli Lilly and Company Pipeline Products & Ongoing Clinical Trials Overview 45
Table 57: Drug Delivery System - Parkinson's Disease - Product Status 45
Table 58: Drug Delivery System - Parkinson's Disease - Product Description 46
Table 59: Flowonix Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
Table 60: Implanted Drug Delivery System - Product Status 47
Table 61: Implanted Drug Delivery System - Product Description 47
Table 62: FluidSynchrony, LLC Pipeline Products & Ongoing Clinical Trials Overview 48
Table 63: FluidSync Pump - Product Status 48
Table 64: FluidSync Pump - Product Description 48
Table 65: Fluonic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
Table 66: SURE+ - Product Status 49
Table 67: SURE+ - Product Description 49
Table 68: Fresenius Kidney Care Pipeline Products & Ongoing Clinical Trials Overview 50
Table 69: Intravenous 2008MeDS - Product Status 50
Table 70: Intravenous 2008MeDS - Product Description 50
Table 71: Imagnus Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
Table 72: DeltaFlow Infusion Regulator - Product Status 51
Table 73: DeltaFlow Infusion Regulator - Product Description 51
Table 74: Innovfusion Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 52
Table 75: DIVA - Product Status 52
Table 76: DIVA - Product Description 52
Table 77: EPIVA - Product Status 53
Table 78: EPIVA - Product Description 53
Table 79: INTRAVA - Product Status 54
Table 80: INTRAVA - Product Description 54
Table 81: Intarcia Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
Table 82: ITCA 638 - Product Status 55
Table 83: ITCA 638 - Product Description 56
Table 84: ITCA 650 Osmotic Pump - Product Status 56
Table 85: ITCA 650 Osmotic Pump - Product Description 57
Table 86: ITCA 880 - Product Status 57
Table 87: ITCA 880 - Product Description 58
Table 88: IRadimed Corporation Pipeline Products & Ongoing Clinical Trials Overview 59
Table 89: MRidium 3860+ MRI IV Pump - Product Status 59
Table 90: MRidium 3860+ MRI IV Pump - Product Description 60
Table 91: Ivenix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
Table 92: Next-Generation Infusion Management System - Product Status 61
Table 93: Next-Generation Infusion Management System - Product Description 62
Table 94: LifeMedix, LLC Pipeline Products & Ongoing Clinical Trials Overview 63
Table 95: STATfusion - Product Status 63
Table 96: STATfusion - Product Description 63
Table 97: Lynntech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
Table 98: Disposable Drug Infusion Pump - Product Status 64
Table 99: Disposable Drug Infusion Pump - Product Description 64
Table 100: Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
Table 101: Medallion Infusion System - Product Status 65
Table 102: Medallion Infusion System - Product Description 65
Table 103: Medical Device Creations Ltd. Pipeline Products & Ongoing Clinical Trials Overview 66
Table 104: Infusion Pump - Product Status 66
Table 105: Infusion Pump - Product Description 66
Table 106: MedPrime Technologies Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67
Table 107: InfuCheck - Product Status 67
Table 108: InfuCheck - Product Description 67
Table 109: Mercator MedSystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68
Table 110: Bullfrog Micro-Infusion Device - Below The Knee - Product Status 68
Table 111: Bullfrog Micro-Infusion Device - Below The Knee - Product Description 69
Table 112: Mercator MedSystems, Inc. - Ongoing Clinical Trials Overview 70
Table 113: Bullfrog Micro-Infusion Device - Below The Knee - Lower-limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherectomy (ATX)-based Revascularization (LIMBO-ATX) 71
Table 114: Bullfrog Micro-Infusion Device - Below The Knee - Lower-limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis after Percutaneous Transluminal Angioplasty Revascularization (LIMBO-PTA) 71
Table 115: Nano Precision Medical Pipeline Products & Ongoing Clinical Trials Overview 72
Table 116: Nano Portal Capsule - Product Status 72
Table 117: Nano Portal Capsule - Product Description 72
Table 118: NexGen Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73
Table 119: PeriCATH - Product Status 73
Table 120: PeriCATH - Product Description 73
Table 121: Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview 74
Table 122: Pump For Venous Anesthesia Infusion - Product Status 74
Table 123: Pump For Venous Anesthesia Infusion - Product Description 75
Table 124: Owen Mumford Limited Pipeline Products & Ongoing Clinical Trials Overview 76
Table 125: UniSafe - Product Status 76
Table 126: UniSafe - Product Description 76
Table 127: Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview 77
Table 128: NextFlo - Product Status 77
Table 129: NextFlo - Product Description 77
Table 130: PRO-IV Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 78
Table 131: Drop Controlling/Counting Valve - Product Status 78
Table 132: Drop Controlling/Counting Valve - Product Description 78
Table 133: Drug Port Verification Valve - Product Status 79
Table 134: Drug Port Verification Valve - Product Description 79
Table 135: Electronic Valve - Product Status 79
Table 136: Electronic Valve - Product Description 79
Table 137: PRIDE System - Product Status 80
Table 138: PRIDE System - Product Description 80
Table 139: Ratio, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
Table 140: NuPrivo - CI - Product Status 81
Table 141: NuPrivo - CI - Product Description 81
Table 142: Rice University Pipeline Products & Ongoing Clinical Trials Overview 82
Table 143: AutoSyP Syringe Pump - Product Status 82
Table 144: AutoSyP Syringe Pump - Product Description 82
Table 145: SteadyMed Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83
Table 146: PatchPump - Product Status 83
Table 147: PatchPump - Product Description 84
Table 148: StnDrd Infusion Corporation Pipeline Products & Ongoing Clinical Trials Overview 85
Table 149: Smart Infusion System - Product Status 85
Table 150: Smart Infusion System - Product Description 85
Table 151: StnDrd Pump - Product Status 86
Table 152: StnDrd Pump - Product Description 86
Table 153: Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 87
Table 154: Short Peripheral Infusion Catheter - Product Status 87
Table 155: Short Peripheral Infusion Catheter - Product Description 87
Table 156: Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview 88
Table 157: Needleless Infusion System - Product Status 88
Table 158: Needleless Infusion System - Product Description 88
Table 159: Terufusion - Product Status 89
Table 160: Terufusion - Product Description 89
Table 161: ToucheMedical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 90
Table 162: Syringe Based Patch Pump - Product Status 90
Table 163: Syringe Based Patch Pump - Product Description 90
Table 164: Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview 91
Table 165: Unilife AutoInfusor - Product Status 91
Table 166: Unilife AutoInfusor - Product Description 92
Table 167: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 93
Table 168: Infusion Micropump - Product Status 93
Table 169: Infusion Micropump - Product Description 94
Table 170: University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 95
Table 171: Drug Infusion Pump - Product Status 95
Table 172: Drug Infusion Pump - Product Description 95
Table 173: Glossary 146

1.2 List of Figures
Figure 1: Drug Delivery Infusion Systems - Pipeline Products by Stage of Development 14
Figure 2: Drug Delivery Infusion Systems - Pipeline Products by Segment 15
Figure 3: Drug Delivery Infusion Systems - Pipeline Products by Territory 16
Figure 4: Drug Delivery Infusion Systems - Pipeline Products by Regulatory Path 17
Figure 5: Drug Delivery Infusion Systems - Pipeline Products by Estimated Approval Date 18
Figure 6: Drug Delivery Infusion Systems - Ongoing Clinical Trials 19

【掲載企業】

410 Medical Innovation, LLC
Acuros GmbH
AktiVax Inc.
Alnylam Pharmaceuticals, Inc.
Anesthesia Safety Products, LLC
AngioDynamics, Inc.
Automedics Medical Systems
Baxter International Inc.
BioCardia, Inc.
Debiotech S.A.
Delpor, Inc.
Edwards Lifesciences Corporation
Eksigent Technologies, LLC
Eli Lilly and Company
Flowonix Medical, Inc.
FluidSynchrony, LLC
Fluonic, Inc.
Fresenius Kidney Care
Imagnus Biomedical Inc.
Innovfusion Pte. Ltd.
Intarcia Therapeutics, Inc.
IRadimed Corporation
Ivenix, Inc.
LifeMedix, LLC
Lynntech, Inc.
Medallion Therapeutics, Inc.
Medical Device Creations Ltd.
MedPrime Technologies Pvt. Ltd.
Mercator MedSystems, Inc.
Nano Precision Medical
NexGen Medical Systems, Inc.
Nipro Corporation
Owen Mumford Limited
Pavmed Inc
PRO-IV Medical Ltd.
Ratio, Inc.
Rice University
SteadyMed Therapeutics, Inc.
StnDrd Infusion Corporation
Tel Aviv University
Terumo Corporation
ToucheMedical Ltd.
Unilife Corporation
University of Minnesota
University of Southern California

★調査レポート[世界の薬物送達注入装置市場:医療機器パイプライン分析2016]販売に関する免責事項
★調査レポート[世界の薬物送達注入装置市場:医療機器パイプライン分析2016]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆